Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2359.58%
operating margin TTM
-3727.75%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.78 |
| peg ratio | -0.13 |
| price to book ratio | -6.39 |
| price to sales ratio | 83.67 |
| enterprise value multiple | -2.03 |
| price fair value | -6.39 |
profitability ratios | |
|---|---|
| gross profit margin | 81.42% |
| operating profit margin | -3727.75% |
| pretax profit margin | -3966.5% |
| net profit margin | -2359.58% |
| return on assets | -279.27% |
| return on equity | 781.16% |
| return on capital employed | 496.76% |
liquidity ratios | |
|---|---|
| current ratio | 0.26 |
| quick ratio | 0.26 |
| cash ratio | 0.22 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 4,037.91 |
| cash conversion cycle | -4,037.91 |
| receivables turnover | 0.00 |
| payables turnover | 0.09 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.73 |
| debt equity ratio | -2.23 |
| long term debt to capitalization | -0.61 |
| total debt to capitalization | 1.81 |
| interest coverage | -12.19 |
| cash flow to debt ratio | -1.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.76 |
| cash per share | 0.11 |
| operating cash flow per share | -0.76 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.58 |
| short term coverage ratios | -1.90 |
| capital expenditure coverage ratio | -232.46 |
Frequently Asked Questions
When was the last time Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported earnings?
Rani Therapeutics Holdings, Inc. (RANI) published its most recent earnings results on 06-11-2025.
What is Rani Therapeutics Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Rani Therapeutics Holdings, Inc. (NASDAQ:RANI)'s trailing twelve months ROE is 781.16%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Rani Therapeutics Holdings, Inc. (RANI) currently has a ROA of -279.27%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RANI's net profit margin stand at?
RANI reported a profit margin of -2359.58% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RANI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.26 in the most recent quarter. The quick ratio stood at 0.26, with a Debt/Eq ratio of -2.23.